|
|
 |
|
Viewing report
|
|
|
|
European Haematology Diagnostics Markets
Frost & Sullivan, Nov 2007, Pages: 140
Laboratory-based Haematology Diagnostics Dominate even as POC-based Tests Make Strong Gains
Since haematology is the first step in any diagnostic procedure, haematology diagnostics will experience sustained growth. Haematology covers a wide array of disease states ranging from blood disorders to rheumatic fever. Since complete blood count (CBC) and haemoglobin assays are the most commonly ordered tests, reagent sales and market demand for these tests will continue to rise over the long term.The market for haematolgy diagnostics in Europe is highly competitive, compelling continued time and investment in research and development. This market is restricted to specialised companies and competition revolves around prominent factors such as price, distribution, promotion strategies and innovation. The market is facing stagnantion, which is restricting both incumbents and propsective entrants.
There is rising demand for rapid tests with alternative technologies such as point-of-care (POC) systems, integrated analysers and automated instruments. The laboratory remains the primary site of testing for haematology diagnostics and is being re-defined by growing automation. Laboratory automation is growing within centralised laboratories to cope with quicker turn around times offered by POC instruments. POC haematology diagnostics is picking up slowly and is anticipated to contribute more towards the market in the future. Awareness of the advantages of POC tests will help promote the growth of POC haematology diagnostics. 'The expansion of the POC haemoglobin (Hb) market is inhibited by the preference for laboratory-based tests; however, there are several factors that ensure that the haematology market continues to grow,' notes the analyst of this research. 'The crucial driving force in the European haematology POCT diagnostics market is that these tests, at a POC level, play a central role in everyday diagnostics and monitoring.' POC tests are gaining preference in some regions, as they generate quick results and assist physicians in identifying optimal treatments.
Demand Rises for Innovative Technologies
The majority of analysers have been in the market for more than two decades. This is creating opportunities for innovative technologies. Increasingly, instruments that were installed more than five years ago are being replaced with newer ones that use novel technologies. These sophisticated analysers cover a wide range of haematological tests and support more rapid and effective sample analysis. As Europe’s population ages, the rate of haematological test has also risen since the urge to remain healthy is motivating older citizens to undergo regular health check-ups. 'The use of POC instruments elevates patient confidence as they have the freedom to perform the tests on their own,' adds the analyst of this research. 'Hence, POC haematology instruments will also offer signficant growth potential.'
A key industry challenge relates to the narrow end-user base; hospitals are the primary site for laboratory analysers, while emergency units and intensive care units are the principal end users of POC haematology analysers. To enhance market expansion, market participants need to build good end-user relationships and promote awareness about POC haematology diagnostics. Automation of analysers will help decrease labour costs, while the incorporation of advanced test menus in analysers will help reduce the costs of individual tests and boost demand.
Market Sectors
The following market sectors are covered in this research:
- Laboratory–based testing
- Point-of-care testing
|
|
|
|
